Targeted Albumin Infusions Do Not Improve Systemic Inflammation or Cardiovascular Function in Decompensated Cirrhosis

China, L; Becares, N; Rhead, C; Tittanegro, T; Freemantle, N; O'Brien, A

China, L (通讯作者),UCL Inst Liver & Digest Hlth, London, England.

CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2022; 13 (5):

Abstract

INTRODUCTION: Albumin is recommended in decompensated cirrhosis, and studies have shown potential immunomodulatory effects. However, 2 large trials of......

Full Text Link